Sofosbuvir

CAS: 1190307-88-0

Ref. TM-T6676

Produktinformation

• Name: Sofosbuvir
• Synonyme: PSI-7977, GS 7977, (S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate, <span class="text-smallcaps">L</span>-Alanine, N-[[P(S),2′R]-2′-deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-, 1-methylethyl ester, Gs-7977, Hepcinat, Hepcvir, Isopropyl (2S)-2-[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propionate, L-Alanine, N-[[p(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-p-phenyl-5'-uridylyl]-, 1-methylethyl ester, Psi 7977, Resof, Sofasbuvir, Sofosbuvir Form6, Sofosvuvir Form6, Sopropyl-(2S)-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl]-4-fluoro-3-hydroxy-4-methy-ltetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate, Sovaldi, Sovihep, sovaldi API

Beschreibung

Sofosbuvir (GS 7977) is a uridine monophosphate analog inhibitor of hepatitis C virus (HCV) polymerase NS5B that is used as an antiviral agent in the treatment

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 529.45
• Formel: C₂₂H₂₉FN₃O₉P
• Reinheit: 99.82% - 99.93%
• Farbe/Form: Solid